Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Viralkumar Shah

Concepts (311)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diabetes Mellitus, Type 1
119
2026
3890
17.840
 Why?
Hypoglycemic Agents
68
2026
1387
13.480
 Why?
Blood Glucose
83
2026
2327
9.280
 Why?
Blood Glucose Self-Monitoring
63
2026
699
8.110
 Why?
Insulin Infusion Systems
39
2026
477
7.940
 Why?
Insulin
53
2026
2507
7.740
 Why?
Hypoglycemia
27
2026
477
5.820
 Why?
Diabetes Mellitus, Type 2
22
2026
2583
4.110
 Why?
Diabetic Retinopathy
7
2026
208
3.950
 Why?
Pancreas, Artificial
9
2025
97
3.100
 Why?
Biosimilar Pharmaceuticals
5
2024
28
2.890
 Why?
Insulin Glargine
7
2025
88
2.870
 Why?
Diabetes Mellitus
12
2026
1098
2.780
 Why?
Diabetic Ketoacidosis
5
2026
210
2.700
 Why?
Osteoporotic Fractures
6
2020
61
2.480
 Why?
Bone Density
12
2025
482
2.470
 Why?
Insulin Aspart
5
2024
30
2.430
 Why?
Adult
98
2026
40449
2.280
 Why?
Fractures, Bone
8
2024
414
2.260
 Why?
Hyperglycemia
8
2024
375
1.900
 Why?
Humans
159
2026
144759
1.880
 Why?
Glucagon-Like Peptides
2
2026
70
1.670
 Why?
Middle Aged
66
2026
35875
1.560
 Why?
Obesity
6
2026
3077
1.500
 Why?
Hyperparathyroidism, Primary
5
2014
7
1.430
 Why?
Young Adult
48
2026
14105
1.400
 Why?
Male
82
2026
72315
1.390
 Why?
Female
86
2026
78271
1.390
 Why?
Diabetes Complications
4
2020
222
1.210
 Why?
Femur Neck
4
2022
62
1.160
 Why?
Peptides
2
2025
995
1.160
 Why?
Practice Guidelines as Topic
2
2026
1560
1.090
 Why?
Sodium-Glucose Transport Proteins
1
2026
3
0.980
 Why?
Adolescent
39
2026
22428
0.940
 Why?
Hypophosphatasia
1
2025
5
0.930
 Why?
Pregnancy in Diabetics
2
2025
121
0.890
 Why?
Marijuana Abuse
2
2019
211
0.890
 Why?
Cannabis
3
2022
509
0.870
 Why?
Liraglutide
1
2024
32
0.870
 Why?
Glucose
6
2023
1047
0.850
 Why?
Treatment Outcome
17
2026
11679
0.820
 Why?
Risk Factors
18
2024
10779
0.810
 Why?
Insulin, Long-Acting
3
2021
65
0.790
 Why?
Bone and Bones
2
2023
314
0.760
 Why?
Sweetening Agents
1
2023
57
0.760
 Why?
Bone Remodeling
2
2020
71
0.760
 Why?
Gastroparesis
2
2019
9
0.740
 Why?
Vitamin D
3
2014
400
0.730
 Why?
Cardiovascular Diseases
6
2022
2168
0.720
 Why?
Machine Learning
2
2025
585
0.720
 Why?
Ketosis
1
2022
12
0.720
 Why?
Registries
10
2021
2385
0.720
 Why?
RNAi Therapeutics
1
2021
6
0.710
 Why?
Hyperoxaluria, Primary
1
2021
14
0.700
 Why?
Insulins
1
2022
38
0.700
 Why?
Patient Satisfaction
2
2025
704
0.680
 Why?
Non-alcoholic Fatty Liver Disease
1
2024
266
0.660
 Why?
Automobile Driving
1
2023
155
0.660
 Why?
Osteoporosis
3
2020
236
0.650
 Why?
Incretins
1
2020
21
0.640
 Why?
Blindness
1
2020
52
0.630
 Why?
Diabetes, Gestational
1
2024
321
0.620
 Why?
Bone Resorption
1
2020
80
0.620
 Why?
Aged
29
2026
25913
0.610
 Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2025
46
0.610
 Why?
Hip Fractures
1
2020
84
0.600
 Why?
Feasibility Studies
1
2024
1095
0.600
 Why?
Self-Management
2
2020
201
0.590
 Why?
Weight Loss
4
2026
836
0.590
 Why?
Age Factors
6
2020
3333
0.580
 Why?
Osteoporosis, Postmenopausal
1
2019
40
0.580
 Why?
Osteogenesis
1
2020
208
0.560
 Why?
Child
24
2026
22633
0.560
 Why?
Absorptiometry, Photon
5
2025
276
0.560
 Why?
Self Care
2
2018
389
0.550
 Why?
Parathyroid Hormone
4
2014
112
0.540
 Why?
Bone Diseases
1
2018
61
0.540
 Why?
Monitoring, Physiologic
1
2019
289
0.520
 Why?
Quality of Life
5
2026
3185
0.510
 Why?
Retrospective Studies
16
2026
17066
0.500
 Why?
Longitudinal Studies
5
2025
2947
0.500
 Why?
Drugs, Investigational
1
2017
31
0.500
 Why?
Body Mass Index
6
2025
2438
0.500
 Why?
Calcium
6
2014
1183
0.490
 Why?
Marijuana Smoking
1
2019
250
0.480
 Why?
Fractures, Spontaneous
1
2015
15
0.470
 Why?
Glucagon-Like Peptide-2 Receptor
2
2025
16
0.450
 Why?
Accidental Falls
1
2018
222
0.450
 Why?
Vitamin D Deficiency
2
2014
186
0.440
 Why?
Gallstones
1
2014
35
0.410
 Why?
Case-Control Studies
7
2026
3604
0.400
 Why?
Glucose Intolerance
1
2015
142
0.400
 Why?
Insulin Lispro
2
2024
42
0.390
 Why?
Prevalence
6
2025
2834
0.390
 Why?
Cross-Sectional Studies
9
2025
5868
0.390
 Why?
Prospective Studies
10
2025
7990
0.380
 Why?
Pancreatitis
1
2014
145
0.380
 Why?
Suicide
1
2020
720
0.360
 Why?
United States
12
2026
15966
0.360
 Why?
Bone Diseases, Metabolic
3
2019
56
0.350
 Why?
Sex Factors
5
2025
2112
0.350
 Why?
Prediabetic State
2
2025
245
0.340
 Why?
Diabetic Angiopathies
3
2020
263
0.340
 Why?
Gastrointestinal Tract
1
2014
208
0.340
 Why?
Surveys and Questionnaires
5
2026
6048
0.340
 Why?
Alkaline Phosphatase
3
2025
145
0.340
 Why?
Algorithms
4
2026
1837
0.330
 Why?
Bromocriptine
2
2025
31
0.330
 Why?
Meals
3
2024
130
0.330
 Why?
Double-Blind Method
2
2026
2029
0.330
 Why?
Autoimmune Diseases
1
2015
463
0.330
 Why?
Islet Amyloid Polypeptide
2
2025
48
0.320
 Why?
Sex Characteristics
3
2025
790
0.310
 Why?
Drug Therapy, Combination
2
2025
1047
0.310
 Why?
Pregnancy
6
2025
7190
0.300
 Why?
Incidence
3
2026
2879
0.300
 Why?
Glucagon-Like Peptide 1
2
2025
146
0.300
 Why?
History, 20th Century
4
2025
325
0.290
 Why?
Autoantibodies
2
2018
1501
0.280
 Why?
Cross-Over Studies
5
2025
601
0.270
 Why?
Risk Assessment
4
2026
3671
0.270
 Why?
Randomized Controlled Trials as Topic
3
2025
1720
0.270
 Why?
Diabetic Nephropathies
2
2024
318
0.270
 Why?
Reference Values
2
2019
797
0.260
 Why?
India
4
2015
218
0.250
 Why?
Metformin
2
2025
318
0.250
 Why?
Phenotype
1
2015
3162
0.250
 Why?
Reproducibility of Results
7
2026
3409
0.240
 Why?
Follow-Up Studies
4
2026
5408
0.230
 Why?
Solid Waste
1
2025
3
0.230
 Why?
Biomedical Research
2
2026
710
0.230
 Why?
Thyrotoxicosis
1
2024
7
0.220
 Why?
Pilot Projects
4
2025
1886
0.220
 Why?
Manitoba
1
2024
4
0.220
 Why?
Phosphates
3
2014
180
0.210
 Why?
Smartphone
1
2025
102
0.210
 Why?
History, 21st Century
3
2025
219
0.200
 Why?
Proof of Concept Study
1
2024
85
0.200
 Why?
Drug Substitution
1
2024
63
0.200
 Why?
ROC Curve
1
2025
614
0.200
 Why?
Artificial Organs
1
2023
2
0.200
 Why?
Glucagon-Like Peptide-1 Receptor
1
2024
88
0.200
 Why?
Information Dissemination
1
2026
223
0.200
 Why?
Clinical Trials as Topic
2
2025
1053
0.200
 Why?
Germany
2
2020
138
0.190
 Why?
Glycemic Index
1
2022
26
0.190
 Why?
Cost-Benefit Analysis
1
2025
634
0.180
 Why?
Disease Progression
3
2026
2847
0.180
 Why?
Minority Groups
2
2023
282
0.180
 Why?
Autonomic Nervous System Diseases
1
2022
34
0.180
 Why?
Gastric Emptying
1
2021
36
0.170
 Why?
Computer Systems
2
2018
56
0.170
 Why?
Vision Screening
1
2021
48
0.170
 Why?
Calibration
2
2018
151
0.170
 Why?
Aged, 80 and over
5
2021
8265
0.170
 Why?
Body Composition
1
2025
706
0.170
 Why?
Biomarkers
3
2023
4271
0.160
 Why?
Diabetic Neuropathies
1
2022
99
0.160
 Why?
Exercise
2
2025
2201
0.160
 Why?
Glucagon-Like Peptide 2
1
2020
7
0.160
 Why?
Regression Analysis
2
2020
1003
0.160
 Why?
Gastric Inhibitory Polypeptide
1
2020
13
0.160
 Why?
Austria
1
2020
8
0.160
 Why?
Energy Intake
1
2023
499
0.160
 Why?
Skiing
1
2021
49
0.160
 Why?
Sensitivity and Specificity
2
2022
1985
0.160
 Why?
Glucagon-Secreting Cells
1
2020
26
0.150
 Why?
Societies, Medical
1
2024
887
0.150
 Why?
Vision Disorders
1
2021
178
0.150
 Why?
RNA Interference
1
2021
476
0.150
 Why?
Psychometrics
2
2021
734
0.150
 Why?
Injections, Subcutaneous
1
2020
164
0.150
 Why?
Time Factors
4
2026
7173
0.150
 Why?
Body Weight
1
2024
976
0.150
 Why?
Insulin Antibodies
1
2020
103
0.150
 Why?
Bone Development
1
2019
52
0.150
 Why?
Fatal Outcome
1
2020
307
0.150
 Why?
Postprandial Period
1
2020
118
0.150
 Why?
Electronic Health Records
2
2025
1173
0.150
 Why?
Radius
1
2019
52
0.140
 Why?
C-Peptide
1
2020
189
0.140
 Why?
Sodium-Glucose Transporter 2
2
2021
29
0.140
 Why?
Healthy Volunteers
1
2019
215
0.140
 Why?
Infusion Pumps, Implantable
1
2018
26
0.140
 Why?
Risk Reduction Behavior
1
2020
226
0.140
 Why?
Patient Acceptance of Health Care
1
2025
885
0.140
 Why?
Cancellous Bone
1
2018
22
0.140
 Why?
Methyldopa
1
2018
6
0.140
 Why?
Social Class
1
2020
268
0.140
 Why?
Benchmarking
1
2019
188
0.140
 Why?
Lumbar Vertebrae
1
2020
252
0.130
 Why?
Sodium Bicarbonate
1
2018
47
0.130
 Why?
Pelvic Bones
1
2020
135
0.130
 Why?
Postmenopause
1
2020
391
0.130
 Why?
Tibia
1
2019
176
0.130
 Why?
HLA-DQ Antigens
1
2018
173
0.130
 Why?
Health Behavior
1
2023
785
0.130
 Why?
Coronavirus Infections
1
2022
378
0.130
 Why?
Computer-Aided Design
1
2017
40
0.130
 Why?
Antigen Presentation
1
2018
205
0.130
 Why?
Health Status Disparities
1
2020
321
0.130
 Why?
Artificial Intelligence
1
2021
365
0.130
 Why?
Uric Acid
1
2018
166
0.130
 Why?
Child, Preschool
4
2026
11787
0.120
 Why?
Hormones
1
2017
134
0.120
 Why?
Antibody Formation
1
2018
294
0.120
 Why?
Glucagon
1
2017
112
0.120
 Why?
Biosensing Techniques
1
2018
139
0.120
 Why?
Immunity, Cellular
1
2018
272
0.120
 Why?
Feeding and Eating Disorders
1
2018
162
0.120
 Why?
Drug Design
1
2017
173
0.120
 Why?
Telemedicine
1
2025
945
0.120
 Why?
Health Personnel
1
2022
748
0.110
 Why?
Insulin-Secreting Cells
1
2020
388
0.110
 Why?
Referral and Consultation
1
2021
851
0.110
 Why?
Drug Overdose
1
2020
370
0.110
 Why?
Automation
2
2025
102
0.110
 Why?
Circadian Rhythm
1
2019
514
0.110
 Why?
Energy Metabolism
1
2020
935
0.100
 Why?
Parathyroidectomy
1
2014
9
0.100
 Why?
Colesevelam Hydrochloride
1
2013
6
0.100
 Why?
Gastrins
1
2013
8
0.100
 Why?
Allylamine
1
2013
6
0.100
 Why?
Sodium-Glucose Transporter 1
1
2013
11
0.100
 Why?
Insulin Detemir
1
2013
8
0.100
 Why?
Dietary Supplements
1
2018
576
0.100
 Why?
Anemia, Iron-Deficiency
1
2014
62
0.100
 Why?
Insulin, Isophane
1
2013
22
0.100
 Why?
Sulfonylurea Compounds
1
2013
51
0.100
 Why?
Chemistry, Pharmaceutical
1
2013
109
0.100
 Why?
Bionics
2
2023
14
0.100
 Why?
Severity of Illness Index
2
2018
2925
0.100
 Why?
Parathyroid Neoplasms
1
2012
12
0.100
 Why?
Thiazolidinediones
1
2013
138
0.090
 Why?
Mutation
1
2024
4089
0.090
 Why?
Abdominal Pain
1
2014
146
0.090
 Why?
Suppuration
1
2012
9
0.090
 Why?
Delayed-Action Preparations
1
2013
183
0.090
 Why?
Recurrence
1
2016
1135
0.090
 Why?
Hypoparathyroidism
1
2012
7
0.090
 Why?
Diabetic Foot
1
2012
25
0.090
 Why?
Dogs
1
2013
437
0.090
 Why?
Cohort Studies
2
2020
5960
0.090
 Why?
Carotid Intima-Media Thickness
1
2012
75
0.090
 Why?
Leptin
1
2013
245
0.090
 Why?
Soft Tissue Infections
1
2012
39
0.090
 Why?
Hemoglobins
1
2014
384
0.090
 Why?
Cholelithiasis
1
2011
36
0.080
 Why?
Swine
1
2013
833
0.080
 Why?
Adenoma
1
2012
218
0.080
 Why?
Osteomyelitis
1
2012
143
0.080
 Why?
T-Lymphocytes
1
2018
1982
0.080
 Why?
Heart Failure
1
2023
2323
0.080
 Why?
Animals
4
2018
38058
0.070
 Why?
Colorado
1
2019
4564
0.070
 Why?
Staphylococcal Infections
1
2012
388
0.070
 Why?
Health Knowledge, Attitudes, Practice
1
2015
1414
0.060
 Why?
Recycling
1
2025
9
0.060
 Why?
National Institutes of Health (U.S.)
1
2026
140
0.060
 Why?
Citric Acid Cycle
1
2024
59
0.050
 Why?
Life Style
1
2025
479
0.050
 Why?
Natriuretic Peptide, Brain
1
2023
111
0.050
 Why?
Socioeconomic Factors
2
2017
1326
0.050
 Why?
Insulin, Regular, Human
1
2022
47
0.050
 Why?
Needles
1
2022
62
0.040
 Why?
Anti-Bacterial Agents
1
2012
1907
0.040
 Why?
Off-Label Use
1
2021
49
0.040
 Why?
Reference Standards
1
2021
177
0.040
 Why?
Oxidation-Reduction
1
2024
1087
0.040
 Why?
Pancreas
1
2023
341
0.040
 Why?
Sodium
1
2021
197
0.040
 Why?
Monitoring, Ambulatory
1
2020
88
0.040
 Why?
Inpatients
1
2023
545
0.040
 Why?
Microscopy, Polarization
1
2018
31
0.030
 Why?
Hepatitis A Virus Cellular Receptor 1
1
2018
41
0.030
 Why?
Osmolar Concentration
1
2018
167
0.030
 Why?
Individuality
1
2019
152
0.030
 Why?
Multicenter Studies as Topic
1
2019
405
0.030
 Why?
Hospitals
1
2022
730
0.030
 Why?
Skin
1
2022
755
0.030
 Why?
Kidney
1
2024
1495
0.030
 Why?
Hydrogen-Ion Concentration
1
2018
561
0.030
 Why?
United Kingdom
1
2017
338
0.030
 Why?
Mice, Inbred NOD
1
2018
610
0.030
 Why?
Prognosis
1
2025
4282
0.030
 Why?
Social Determinants of Health
1
2020
301
0.030
 Why?
Patient Compliance
1
2020
588
0.030
 Why?
Creatinine
1
2018
506
0.030
 Why?
Insulin Resistance
1
2024
1241
0.030
 Why?
Patient Reported Outcome Measures
1
2020
488
0.030
 Why?
Hospitalization
1
2025
2433
0.030
 Why?
Culture
1
2015
125
0.030
 Why?
Dose-Response Relationship, Drug
1
2019
2027
0.030
 Why?
Erythrocyte Indices
1
2014
33
0.030
 Why?
Glomerular Filtration Rate
1
2018
760
0.030
 Why?
Disease Management
1
2018
645
0.030
 Why?
Cholecalciferol
1
2014
60
0.030
 Why?
Home Care Services
1
2017
280
0.030
 Why?
Emergency Service, Hospital
1
2025
2310
0.020
 Why?
Calcifediol
1
2012
31
0.020
 Why?
Mice, Transgenic
1
2018
2182
0.020
 Why?
Parents
1
2021
1403
0.020
 Why?
Tomography, X-Ray Computed
1
2022
2730
0.020
 Why?
Research Design
1
2017
1135
0.020
 Why?
Microbial Sensitivity Tests
1
2012
370
0.020
 Why?
Drug Resistance, Bacterial
1
2012
196
0.020
 Why?
Tourniquets
1
2011
34
0.020
 Why?
Serum Albumin
1
2011
147
0.020
 Why?
Fasting
1
2011
277
0.020
 Why?
Infant
1
2019
10034
0.010
 Why?
Mice
1
2018
18339
0.010
 Why?
Shah's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (311) concept(s)
_
Co-Authors Expand Description
See all (41) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)